TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.

Herbert I Hurwitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.